Morning Break: Wrongful Birth, NOAC Safety, Psoriasis Drug Revived


  • by

You've heard of wrongful death, but how about wrongful birth? And did you know it's worth $50 million? (The Pathology Blawg)

Medicine for Real fires back at that New York Times op-ed about bad doctors happening to good people.

California's assisted suicide bill will be considered in a special session starting today, Reuters reports.

At Psychiatric Times, Allen Frances argues that medical education has become "too technical" and is losing its human focus.

Jen Gunter says Medscape "helped stack the deck for Addyi," the female libido booster.

Brodalumab, a psoriasis drug with potential safety issues, has a new developer after Amgen dropped it last May. (Reuters)

Sugar causes a lot of harm, but its relation to obesity is complicated.

Very few people hear about those who die when the FDA fails to approve a good drug. Is the FDA too conservative? (Marginal Revolution)

A combination of two Novartis drugs, dabrafenib and trametinib, won approval in the European Union for melanoma treatment, the company said.

How safe is that NOAC? (Frugal Nurse) And here is what MedPage Today/Milwaukee Journal Sentinel had to say about NOAC safety.

A patient was killed after blowing himself up trying to smoke in a high-pressure oxygen chamber where he was seeking treatment (Daily Mail).

In Pakistan, more than 70% of medical students are women -- but only 27% of registered doctors are. (BBC)
